Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction. A 35-year-old patient on her 12th day post-delivery presents progressive signs of heart fai...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2015
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24997
- Acceso en línea:
- https://doi.org/10.14740/jocmr2323w
https://repository.urosario.edu.co/handle/10336/24997
- Palabra clave:
- Cardiorespiratory Medicine and Haematology
Medical and Health Sciences
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_0376c7938aa0c62849c0e3790e72e78b |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/24997 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
d0cbbaa9-ff7b-484a-bb2c-9f25ddb8c870-1fedddac8-704b-4df3-a1c4-1e4b3101fd2b-187e3a6f3-f1ee-40c4-89ec-89cedd5e5bec-12b480db8-d121-43c7-acfb-f23d859c210d-135ec42c5-4d19-4d0c-a9c6-ed85995ff317-199b40276-a33d-401e-a27a-417285acf4e2-12020-06-11T13:22:02Z2020-06-11T13:22:02Z2015Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction. A 35-year-old patient on her 12th day post-delivery presents progressive signs of heart failure. Transthoracic echocardiography showed severe mitral insufficiency, mild left ventricular dysfunction, mild tricuspid insufficiency, severe pulmonary hypertension, and right atrial enlargement. With wet and cold heart failure signs, the patient was a candidate for inodilator cardiovascular support and volume depletion therapy. As the patient presented a persistent tachycardia at rest, levosimendan was chosen over dobutamine. Levosimendan was administered at a dose of 0.2 g/kg/min during a period of 24 hours. After inodilator therapy, the patient's signs and symptoms of heart failure began to decrease, showing improvement of dyspnea, mitral murmur grade went from IV/IV to II/IV, filling pressures and systemic and pulmonary resistance indexes decreased, arterial blood gases improved, and an echocardiography performed 72 h later showed non-dilated cardiomyopathy, mild cardiac contractile dysfunction, mild mitral insufficiency, type I diastolic dysfunction and improvement of pulmonary hypertension. Cardiovascular function in peripartum cardiomyopathy tends to go back to normality in 23-41% of the cases, but in a large group of patients, severe ventricle dysfunction remains months after initial symptoms. This article describes the diagnostic process of a patient with peripartum cardiomyopathy and a successful reversion of a severe case of mitral insufficiency using levosimendan as a new therapeutic strategy in this clinical context.application/pdfhttps://doi.org/10.14740/jocmr2323whttps://repository.urosario.edu.co/handle/10336/24997engJournal of Clinical Medicine Research1001No. 12998Journal of Clinical Medicine ResearchVol. 7Journal of Clinical Medicine Research, ISSN: , Vol.7, No.12 (2015); pp. 998-1001https://www.jocmr.org/index.php/JOCMR/article/download/2323/1314Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCardiorespiratory Medicine and HaematologyMedical and Health SciencesReversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using LevosimendanarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Estrada, Victor H. NietoFranco, Daniel L. MolanoMoreno, Albert Alexander ValenciaGambasica, Jose A. RojasBornacelli, Yamil E. JallerDel Valle, Anacaona MartinezORIGINAL2323-12474-1-PB.pdfapplication/pdf1281755https://repository.urosario.edu.co/bitstreams/53c9ea9c-10b1-4392-903a-a169d90a1a94/download5740a8c76ed8219a2636acdfe8ab940eMD51TEXT2323-12474-1-PB.pdf.txt2323-12474-1-PB.pdf.txtExtracted texttext/plain19172https://repository.urosario.edu.co/bitstreams/119d73d4-e005-4b9e-9a9c-1434b336e806/downloaddf31166dc3a0f1fc6cf7c0d368361897MD52THUMBNAIL2323-12474-1-PB.pdf.jpg2323-12474-1-PB.pdf.jpgGenerated Thumbnailimage/jpeg4289https://repository.urosario.edu.co/bitstreams/a79d75bc-e15b-4078-8090-b1cfb0bbb21e/downloadc4e1b52eed187284f851fdcb9d96b2dfMD5310336/24997oai:repository.urosario.edu.co:10336/249972021-06-03 00:50:51.85https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan |
title |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan |
spellingShingle |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan Cardiorespiratory Medicine and Haematology Medical and Health Sciences |
title_short |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan |
title_full |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan |
title_fullStr |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan |
title_full_unstemmed |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan |
title_sort |
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan |
dc.subject.keyword.spa.fl_str_mv |
Cardiorespiratory Medicine and Haematology Medical and Health Sciences |
topic |
Cardiorespiratory Medicine and Haematology Medical and Health Sciences |
description |
Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction. A 35-year-old patient on her 12th day post-delivery presents progressive signs of heart failure. Transthoracic echocardiography showed severe mitral insufficiency, mild left ventricular dysfunction, mild tricuspid insufficiency, severe pulmonary hypertension, and right atrial enlargement. With wet and cold heart failure signs, the patient was a candidate for inodilator cardiovascular support and volume depletion therapy. As the patient presented a persistent tachycardia at rest, levosimendan was chosen over dobutamine. Levosimendan was administered at a dose of 0.2 g/kg/min during a period of 24 hours. After inodilator therapy, the patient's signs and symptoms of heart failure began to decrease, showing improvement of dyspnea, mitral murmur grade went from IV/IV to II/IV, filling pressures and systemic and pulmonary resistance indexes decreased, arterial blood gases improved, and an echocardiography performed 72 h later showed non-dilated cardiomyopathy, mild cardiac contractile dysfunction, mild mitral insufficiency, type I diastolic dysfunction and improvement of pulmonary hypertension. Cardiovascular function in peripartum cardiomyopathy tends to go back to normality in 23-41% of the cases, but in a large group of patients, severe ventricle dysfunction remains months after initial symptoms. This article describes the diagnostic process of a patient with peripartum cardiomyopathy and a successful reversion of a severe case of mitral insufficiency using levosimendan as a new therapeutic strategy in this clinical context. |
publishDate |
2015 |
dc.date.created.spa.fl_str_mv |
2015 |
dc.date.accessioned.none.fl_str_mv |
2020-06-11T13:22:02Z |
dc.date.available.none.fl_str_mv |
2020-06-11T13:22:02Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.14740/jocmr2323w |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/24997 |
url |
https://doi.org/10.14740/jocmr2323w https://repository.urosario.edu.co/handle/10336/24997 |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
1001 |
dc.relation.citationIssue.none.fl_str_mv |
No. 12 |
dc.relation.citationStartPage.none.fl_str_mv |
998 |
dc.relation.citationTitle.none.fl_str_mv |
Journal of Clinical Medicine Research |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 7 |
dc.relation.ispartof.spa.fl_str_mv |
Journal of Clinical Medicine Research, ISSN: , Vol.7, No.12 (2015); pp. 998-1001 |
dc.relation.uri.spa.fl_str_mv |
https://www.jocmr.org/index.php/JOCMR/article/download/2323/1314 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Journal of Clinical Medicine Research |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
bitstream.url.fl_str_mv |
https://repository.urosario.edu.co/bitstreams/53c9ea9c-10b1-4392-903a-a169d90a1a94/download https://repository.urosario.edu.co/bitstreams/119d73d4-e005-4b9e-9a9c-1434b336e806/download https://repository.urosario.edu.co/bitstreams/a79d75bc-e15b-4078-8090-b1cfb0bbb21e/download |
bitstream.checksum.fl_str_mv |
5740a8c76ed8219a2636acdfe8ab940e df31166dc3a0f1fc6cf7c0d368361897 c4e1b52eed187284f851fdcb9d96b2df |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167504637919232 |